StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
LGVN

Longeveron Inc.

LGVN Nasdaq Pharmaceutical Preparations EDGAR ↗
$0.73
+0.06 +8.44%

Key statistics

from XBRL data in SEC filings
Market cap
$18.1B
Revenue (TTM)
$1.22M
Net income (TTM)
-$22.4M
EPS (TTM)
$-1.14
P/E ratio
Dividend yield
Free cash flow
-$18.9M
Cash
$15.8M
Total assets
$21.2M
Gross margin
65.1%
52-week range
$0.48 – $1.75

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Other events Jul 29, 2026 8-K Director or officer change Jul 14, 2026 8-K Director or officer change Jul 8, 2026 8-K Director or officer change; Amended charter or bylaws; Shareholder vote results Jul 6, 2026 8-K Director or officer change Jun 5, 2026 8-K Results of operations (earnings release) May 13, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Other events May 8, 2026 8-K Director or officer change Apr 10, 2026 8-K Delisting notice or listing-rule failure Mar 25, 2026 8-K Other events Mar 24, 2026 10-K Fiscal year ended 2025-12-31 Mar 17, 2026 8-K Entered a material agreement; Unregistered sale of equity; Amended charter or bylaws; Other events Mar 12, 2026 8-K Delisting notice or listing-rule failure; Director or officer change Mar 9, 2026 8-K Director or officer change Feb 13, 2026 8-K Director or officer change Nov 12, 2025 8-K Results of operations (earnings release) Nov 4, 2025 10-Q Quarter ended 2025-09-30 Nov 4, 2025 8-K Director or officer change Oct 1, 2025 8-K Delisting notice or listing-rule failure Sep 26, 2025 8-K Entered a material agreement Sep 19, 2025 8-K Director or officer change Sep 3, 2025 8-K Results of operations (earnings release) Aug 13, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 8-K Entered a material agreement; Other events Aug 11, 2025 8-K Other events Jul 9, 2025 8-K Shareholder vote results Jun 16, 2025 8-K Results of operations (earnings release) May 8, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Director or officer change May 1, 2025 8-K Changed accountants Mar 14, 2025 8-K Results of operations (earnings release) Feb 28, 2025 10-K Fiscal year ended 2024-12-31 Feb 28, 2025 8-K Director or officer change Jan 30, 2025 8-K Results of operations (earnings release) Nov 12, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Aug 14, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Entered a material agreement; Unregistered sale of equity; Other events Jul 19, 2024 8-K Other events Jul 17, 2024